Developing a new drug to cure chronic hepatitis B virus infection
ANTIVIRAL DRUGS TO CURE CHRONIC HEPATITIS B VIRUS INFECTION
This study is working on a new antiviral medicine to help people with chronic hepatitis B, and if you join, you could help test how well it works and if it's safe, which could lead to better treatment options for everyone dealing with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hbvtech NIH-funded |
| Lab location | 1 site (Germantown, United States) |
| Project ID | NIH-10821260 on NIH RePORTER |
What this research studies
This research focuses on creating a new antiviral drug aimed at curing chronic hepatitis B virus (HBV) infection. The approach involves the development and testing of antiviral agents that target the virus effectively. Patients may be involved in clinical trials to evaluate the safety and efficacy of these new treatments, which could lead to significant improvements in managing HBV. The research aims to provide a long-term solution for individuals suffering from this chronic infection.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with chronic hepatitis B virus infection.
Not a fit: Patients who do not have chronic hepatitis B virus infection will not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a cure for chronic hepatitis B, significantly improving the quality of life for affected patients.
How similar studies have performed: While there have been advancements in antiviral treatments for hepatitis B, this specific approach is novel and aims to provide a definitive cure.
Where this research is happening
Germantown, United States
- Hbvtech — Germantown, United States (Active)
Researchers
- Principal investigator: Zhang, Yang-Yuan — Hbvtech
- Study coordinator: Zhang, Yang-Yuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.